| Cash and equivalents |
4.05M |
| Short-term investments |
10.88M |
| Accounts receivable |
1.42M |
| Other current assets |
603.79K |
| Total current assets |
16.95M |
| Computer equipment |
| Lab equipment |
| Furniture |
| Property, Plant and Equipment, Gross, Total |
| Less accumulated depreciation |
| Property, Plant and Equipment, Net, Total |
45.79K |
| Intellectual property |
| Other long term assets |
30.46K |
| Deposits |
| Assets Noncurrent excluding Property, Plant and Equipment |
| TOTAL ASSETS |
17.03M |
| Accounts payable |
186.86K |
| Deferred revenue |
0 |
| Accrued expenses |
1.25M |
| Accrued bonuses |
| Accrued warrant liability |
1.35M |
| Total current liabilities |
2.79M |
| Deferred revenue |
| Total long term liabilities |
| Commitments and contingencies - See Note 9 |
0 |
| Common stock, $.005 par value Authorized - 80,000,000 shares at June 30, 2011 and December 31, 2010 Issued and outstanding 35,373,096 and 28,959,176 shares at June 30, 2011 and December 31, 2010, respectively |
54.93K |
| Additional paid-in capital |
| Accumulated other comprehensive income (loss) |
-407.59K |
| Accumulated deficit |
-149.51M |
| Total Cleveland BioLabs, Inc. stockholders' equity (deficit) |
8.91M |
| Noncontrolling Interest in stockholders' equity |
5.33M |
| Total stockholders' equity (deficit) |
14.24M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
17.03M |
